Dabigatran versus warfarin in patients with atrial fibrillation.
Dabigatran versus warfarin in patients with atrial fibrillation.
S. Connolly,M. Ezekowitz,17 Authors,L. Wallentin
2009 · DOI: 10.1056/NEJMoa0905561
New England Journal of Medicine · 9,843 Citations
TLDR
In patients with atrial fibrillation, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to those associated with warfarin, as well as lower rates of major hemorrhage.